• 1
    Daminet S., Paradis M., Refsal KR, et al. Short-term influence of prednisone and phenobarbital on thyroid function in euthyroid dogs. Can Vet J 1999;40:411415.
  • 2
    Gaskill CL, Burton SA, Gelens HC, et al. Effects of phenobar-bital treatment on serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs. J Am Vet Med Assoc 1999;215:489496.
  • 3
    Hall IA, Campbell KL, Chambers MD, et al. Effect of trimeth-oprim/sulfamethoxazole on thyroid function in dogs with pyoderma. J Am Vet Med Assoc 1993;202:19591962.
  • 4
    Kantrowitz LB, Peterson ME, Trepanier LA, et al. Serum total thyroxine, total triiodothyronine, free thyroxine, and thyrotropin concentrations in epileptic dogs treated with anticonvulsants. J Am Vet Med Assoc 1999;214:18041808.
  • 5
    Muller PB, Wolfsheimer KJ, Taboada J., et al. Effects of long-term phenobarbital treatment on the thyroid and adrenal axis and adrenal function tests in dogs. J Vet Intern Med 2000;14:157164.
  • 6
    Torres SM, McKeever PJ, Johnston SD. Effect of oral administration of prednisolone on thyroid function in dogs. Am J Vet Res 1991;52:416421.
  • 7
    Earle BV. Thyroid hormone and tricyclic antidepressants in resistant depressions. Am J Psychiatry 1970;126:16671669.
  • 8
    Kusalic M., Engelsmann F., Bradwejn J. Thyroid functioning during treatment for depression. J Psychiatry Neurosci 1993; 18: 260263.
  • 9
    Martin P., Massol J., Belon JP, et al. Thyroid function and reversal by antidepressant drugs of depressive-like behavior (escape deficits) in rats. Neuropsychobiology 1987;18:2126.
  • 10
    Massol J., Martin P., Chatelain F., et al. Tricyclic antidepressants, thyroid function, and their relationship with the behavioral responses in rats. Biol Psychiatry 1990;28:967978.
  • 11
    Dumas ML, Pons F., Cadilhac J. Histochemical data on the re-uptake blockade of monoamines by chlomipramine [in French; authors' translation]. Ann Histochim 1975;20:283290.
  • 12
    Peters MD, Davis SK, Austin LS. Clomipramine: An antiob-sessional tricyclic antidepressant. Clin Pharm 1990;9:165178.
  • 13
    Hewson CJ, Conlon PD, Luescher UA, et al. The pharmaco-kinetics of clomipramine and desmethylclomipramine in dogs: Parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine. J Vet Pharmacol Ther 1998;21:214222.
  • 14
    Martensson B., Wagner A., Beck O., et al. Effects of clomipra-mine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder. Acta Psychiatr Scand 1991;83:125133.
  • 15
    Noguchi T., Shimoda K., Takahashi S. Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: Prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data. J Affect Disord 1993;29:267279.
  • 16
    Buxeraud J., Absil AC, Raby C. Secondary antithyroid action of drugs in relation to structure. J Pharm Sci 1984;73:16871690.
  • 17
    Rousseau A., Comby F., Buxeraud J., et al. Spectroscopic analysis of charge transfer complex formation and peroxidase inhibition with tricyclic antidepressant drugs: Potential anti-thyroid action. Biol Pharm Bull 1996;19:726728.
  • 18
    Sauvage MF, Marquet P., Rousseau A., et al. Relationship between psychotropic drugs and thyroid function: A review. Toxicol Appl Pharmacol 1998;149:127135.
  • 19
    Sokolov ST, Levitt AJ, Joffe RT. Thyroid hormone levels before unsuccessful antidepressant therapy are associated with later response to T3 augmentation. Psychiatry Res 1997;69:203206.
  • 20
    Wilson IC, Prange AJ Jr, McClane TK, et al. Thyroid-hormone enhancement of imipramine in nonretarded depressions. N Engl J Med 1970;282:10631067.
  • 21
    Reinhard D. Aggressive behavior associated with hypothyroid-ism. Canine Pract 1978;5:69.
  • 22
    Dodman NH, Mertens PA, Aronson LP. Animal behavior case of the month. Dogs were evaluated because of aggression. J Am Vet Med Assoc 1995; 207: 11681171.
  • 23
    Ferguson DC. Update on diagnosis of canine hypothyroidism. Vet Clin North Am Small Anim Pract 1994;24:515539.
  • 24
    Scott-Moncrieff JC, Nelson RW. Change in serum thyroid-stimulating hormone concentration in response to administration of thy-rotropin-releasing hormone to healthy dogs, hypothyroid dogs, and euthyroid dogs with concurrent disease. J Am Vet Med Assoc 1998; 213:14351438.
  • 25
    Scott-Moncrieff JC, Nelson RW, Bruner JM, et al. Comparison of serum concentrations of thyroid-stimulating hormone in healthy dogs, hypothyroid dogs, and euthyroid dogs with concurrent disease. J Am Vet Med Assoc 1998;212:387391.
  • 26
    Panciera DL, Post K. Effect of oral administration of sulfadia-zine and trimethoprim in combination on thyroid function in dogs. Can J Vet Res 1992;56:349352.
  • 27
    Center SA, Mitchell J., Nachreiner RF, et al. Effects of propranolol on thyroid function in the dog. Am J Vet Res 1984;45:109111.
  • 28
    Miller AB, Nelson RW, Scott-Moncrieff JC, et al. Serial thyroid hormone concentrations in healthy euthyroid dogs, dogs with hypo-thyroidism, and euthyroid dogs with atopic dermatitis. Br Vet J 1992; 148:451458.
  • 29
    Panciera DL, MacEwen EG, Atkins CE, et al. Thyroid function tests in euthyroid dogs treated with L-thyroxine. Am J Vet Res 1990; 51:2226.
  • 30
    Panciera DL, Johnson GS. Plasma von Willebrand factor antigen concentration in dogs with hypothyroidism. J Am Vet Med Assoc 1994;205:15501553.
  • 31
    Gaskill CL, Burton SA, Gelens HC, et al. Changes in serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs receiving phenobarbital for one year. J Vet Pharmacol Ther 2000; 23:243249.
  • 32
    Langer G., Resch F., Aschauer H., et al. TSH-response patterns to TRH stimulation may indicate therapeutic mechanisms of antide-pressant and neuroleptic drugs. Neuropsychobiology 1984;11:211218.
  • 33
    de Montigny C., Agajanian GK. Tricyclic antidepressants: Long term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978;202:13031306.
  • 34
    Blier P., de Montigny C., Chaput Y. Modifications of the serotonin system by antidepressant treatments: Implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987; 7: 24S35S.
  • 35
    McTavish D., Benfield P. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 1990; 39: 136153.
  • 36
    Mårtensson E., Axelsson R., Nyberg G. Pharmacokinetic properties of the antidepressant drugs amitriptyline, clomipramine, and imipramine: A clinical study. Curr Ther Res 1984;36:228.
  • 37
    Lagorce JF, Thomes JC, Catanzano G., et al. Formation of molecular iodine during oxidation of iodide by the peroxidase/H2O2 system. Implications for antithyroid therapy. Biochem Pharmacol 1991; 42(Suppl):S89S92.
  • 38
    King JN, Maurer MP, Altmann BO, et al. Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration. Am J Vet Res 2000;61:8085.
  • 39
    Rousseau A., Marquet P., Lagorce JF, et al. Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration. Pharmacology 1998;57:242248.
  • 40
    Campos-Barros A., Meinhold H., Stula M., et al. The influence of desipramine on thyroid hormone metabolism in rat brain. J Pharmacol Exp Ther 1994;268:11431152.
  • 41
    Belshaw BE, Barandes M., Becker DV, et al. A model of iodine kinetics in the dog. Endocrinology 1974;95:10781093.
  • 42
    Wu SY. Thyrotropin-mediated induction of thyroidal iodothy-ronine monodeiodinases in the dog. Endocrinology 1983;112:417424.
  • 43
    Meij BP, Mol JA, Rijnberk A. Thyroid-stimulating hormone responses after single administration of thyrotropin-releasing hormone and combined administration of four hypothalamic releasing hormones in beagle dogs. Domest Anim Endocrinol 1996;13:465468.
  • 44
    Morley JE, Brammer GL, Sharp B., et al. Neurotransmitter control of hypothalamic-pituitary-thyroid function in rats. Eur J Pharmacol 1981;70:263271.
  • 45
    Brady KT, Anton RF. The thyroid axis and desipramine treatment in depression. Biol Psychiatry 1989;25:703709.
  • 46
    Prange AJ Jr. Psychotropic drugs and the thyroid axis: A review of interactions. Adv Biochem Psychopharmacol 1985;40:103110.
  • 47
    Schlienger JL, Kapfer MT, Singer L., et al. The action of clo-mipramine on thyroid function. Horm Metab Res 1980;12:481482.